MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MSD Pharmaceuticals Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11509
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and pharmaceutical products, among others. It also offers vaccines, women’s healthcare products, critical care products, chronic care products, and healthcare products. MSD India’s therapeutic areas include human health, metabolics, cardiovascular, vaccines, critical care, immunology, virology, oncology, women’s health, dermatology, respiratory, musculoskeletal, and primary care. The company operates in Australia, Austria, Belgium, Canada, Romania, Denmark, Egypt, Finland, France, Germany, Hungary, Japan, Malaysia, Taiwan, and Thailand. MSD India is headquartered in Mumbai, Maharashtra, India.

MSD Pharmaceuticals Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MSD India Plans Co-Marketing Agreement For Diabetes Drugs 10
Licensing Agreements 11
Cipla Enters Into Licensing Agreement With MSD Pharma For Raltegravir 11
Asset Transactions 13
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 13
MSD Pharmaceuticals Pvt Ltd – Key Competitors 14
MSD Pharmaceuticals Pvt Ltd – Key Employees 15
MSD Pharmaceuticals Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD India Plans Co-Marketing Agreement For Diabetes Drugs 10
Cipla Enters Into Licensing Agreement With MSD Pharma For Raltegravir 11
Piramal Enterprises Acquires Five OTC Brands from Organon India and MSD for USD14 Million 13
MSD Pharmaceuticals Pvt Ltd, Key Competitors 14
MSD Pharmaceuticals Pvt Ltd, Key Employees 15

List of Figures
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD Pharmaceuticals Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sonova Holding AG:企業の戦略・SWOT・財務情報
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CorEnergy Infrastructure Trust Inc (CORR):石油・ガス:M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • Phytel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality …
  • Energy Fuels Inc (EFR):企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Regulus Therapeutics Inc (RGLS):医療機器:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Nice Ltd (NICE):企業の財務・戦略的SWOT分析
    Nice Ltd (NICE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • National Institutes of Health:企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • RFIB Group Limited:企業の戦略・SWOT・財務情報
    RFIB Group Limited - Strategy, SWOT and Corporate Finance Report Summary RFIB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • Integrated Device Technology Inc (IDTI):企業の財務・戦略的SWOT分析
    Integrated Device Technology Inc (IDTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kuwait Oil Co:企業の戦略的SWOT分析
    Kuwait Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務分析
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GE Healthcare LLC:医療機器:M&Aディール及び事業提携情報
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Monotype Imaging Holdings Inc (TYPE):企業の財務・戦略的SWOT分析
    Summary Monotype Imaging Holdings Inc (Monotype Imaging) is a technology company, which offers text imaging solutions. The company’s products include embedded solutions and olapic earned content platform. Its solutions comprise imaging solutions for print, web and mobile environments. Monotype Imagi …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • China Aerospace Science and Technology Corporation:企業の戦略・SWOT・財務情報
    China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆